Evidence-based·Last reviewed May 31, 2026·How we grade evidence

Noni

BotanicalBest in the morning

Noni is a Polynesian fruit juice marketed for everything from cancer to fatigue, but the human evidence for any benefit is thin — and the case reports of acute hepatitis (some severe, including liver transplant) make it one of the few popular botanicals with a genuine safety story to take seriously.

Quick decision guide

May help most

There's no clearly evidence-supported indication. People sometimes drink it for fatigue or joint pain, but trials are small and outcomes inconsistent.

Common dosing range

30–750 mL/day of commercial Tahitian Noni juice has been used in trials; the NCI phase I tolerated up to 12 oz four times daily short-term.

When to expect effects

Trials measured outcomes over 4 weeks to 3 months; no clinical endpoint has been consistently demonstrated.

Watch out for

Multiple case reports of acute hepatitis — including a transplant case — link noni juice to liver injury. Avoid if you have liver disease or take hepatotoxic medications.

Evidence snapshot

Cancer outcomesPhase I safety only
Oxidative stress (smokers)One RCT
Joint pain / fatigueInconsistent
Hepatotoxicity riskReal signal

What is it

Noni (Morinda citrifolia) is a small tropical fruit from the coffee family, native to Southeast Asia and the Pacific islands. The fruit, sometimes called Indian mulberry or cheesefruit due to its pungent odor when ripe, is consumed primarily as juice and is used in traditional Polynesian medicine.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if

You've already tried other evidence-based options for whatever you're hoping noni will help with
You have no liver disease, aren't on hepatotoxic medications, and accept the case-report risk signal
You're willing to stop at any sign of fatigue, jaundice, dark urine, or right-upper-quadrant pain and get LFTs checked

Probably skip if

You have any liver disease (hepatitis B/C, NAFLD, cirrhosis) or elevated baseline liver enzymes
You take other hepatotoxic drugs (acetaminophen at high doses, methotrexate, isoniazid, anti-TB regimens, amiodarone)
You're using it as a cancer treatment instead of evidence-based oncology
You're hoping for a specific clinical benefit (joint pain, fatigue, immunity) — small trials don't consistently show it
You're pregnant or breastfeeding — no safety data, and the hepatotoxicity signal is a real concern

Evidence at a glance

Oxidative stress in heavy smokers

Limited Evidence
Effect
Significant reductions in MDA and DNA adducts vs placebo in smokers; clinical relevance unproven
Best fit
Heavy smokers interested in a biomarker-level intervention; smoking cessation is far higher-leverage
Time
30 days in the published trial

Cancer (adjunct or treatment)

Mixed Evidence
Effect
No measured anti-cancer clinical-endpoint benefit in any controlled trial
Best fit
None for cancer treatment; phase I was advanced disease and explicitly a safety study
Time
Not established for any cancer endpoint

Joint pain / arthritis

Mixed Evidence
Effect
Inconsistent across small trials; no high-quality RCT confirms benefit
Best fit
None on current evidence
Time
Variable across trials (4–12 weeks)

Fatigue / general well-being

Mixed Evidence
Effect
Anecdotal / open-label improvements; no rigorous trial demonstrates a meaningful effect
Best fit
None on current evidence
Time
Variable, mostly self-reported

Evidence for 4 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

Oxidative stress in heavy smokers

Biomarker support
Limited Evidence

A 30-day placebo-controlled RCT in 283 heavy smokers (Wang 2009) found 14 oz/day Tahitian Noni juice reduced plasma SOD and MDA and lowered aromatic DNA adducts in peripheral lymphocytes. This is a biomarker change, not a clinical-outcome benefitit doesn't tell you whether cancer risk or lung function actually changes. Replication is sparse.

Effect size
Significant reductions in MDA and DNA adducts vs placebo in smokers; clinical relevance unproven
Time to effect
30 days in the published trial
Best fit
Heavy smokers interested in a biomarker-level intervention; smoking cessation is far higher-leverage
Less likely
Non-smokers; people seeking proven clinical-endpoint benefit

Bottom line: One real RCT showed antioxidant biomarker improvements in smokers. Don't extrapolate to disease prevention.

Cancer (adjunct or treatment)

Mechanism only
Mixed Evidence

The NCI-funded phase I trial in 51 patients with advanced cancer was a safety/dose-finding studyit established that noni juice up to 12 oz four times daily is short-term tolerable, but it was not designed to test efficacy. No randomized, controlled, efficacy trial in any cancer has been published. Consumer marketing routinely cites this phase I as if it demonstrated benefit; it doesn't.

Effect size
No measured anti-cancer clinical-endpoint benefit in any controlled trial
Time to effect
Not established for any cancer endpoint
Best fit
None for cancer treatment; phase I was advanced disease and explicitly a safety study
Less likely
Anyone using noni instead of established oncologic care

Bottom line: No human efficacy evidence. Do not use as a cancer treatment in place of evidence-based oncology.

Joint pain / arthritis

Mechanism only
Mixed Evidence

Small, mostly open-label or low-quality trials have explored noni for arthritis and joint pain with inconsistent results. The 2018 West review concluded the data are insufficient to recommend noni for joint pain; effect sizes when reported are modest and study quality limits confidence.

Effect size
Inconsistent across small trials; no high-quality RCT confirms benefit
Time to effect
Variable across trials (4–12 weeks)
Best fit
None on current evidence
Less likely
Patients seeking established treatments for arthritis — NSAIDs, exercise, weight management

Bottom line: Insufficient evidence. Stick with established options for joint pain.

Fatigue / general well-being

Mechanism only
Mixed Evidence

A handful of small underpowered trials and survey reports describe subjective improvements in energy, sleep, and mood with regular noni juice consumption. None is a high-quality RCT with validated outcomes. The 2018 West review notes the persistent gap between marketing and the underlying clinical evidence base.

Effect size
Anecdotal / open-label improvements; no rigorous trial demonstrates a meaningful effect
Time to effect
Variable, mostly self-reported
Best fit
None on current evidence
Less likely
Anyone who would prefer an evidence-based intervention for fatigue

Bottom line: Marketing is loud; trials are quiet and inconclusive.

How it works

Noni fruit contains a variety of bioactive compounds including iridoids (notably deacetylasperulosidic acid), polysaccharides, scopoletin, anthraquinones, and damnacanthal. The specific compound or mechanism responsible for noni's traditional medicinal uses remains unclear, with most research focused on isolated compounds rather than the whole fruit. Laboratory and animal studies have suggested antioxidant, anti-inflammatory, antimicrobial, and possible analgesic effects from various noni compounds. Iridoids are thought to be among the more important bioactives. Human clinical evidence remains limited and mostly comes from small or industry-sponsored trials. Noni juice is typically aged (fermented) for several weeks before consumption, which alters its chemical profile and reduces some of the unpleasant odor compounds. Commercial noni juice products often blend with grape, blueberry, or other juices to mask the strong taste.

How to take it

1. Typical dose
• 30–60 mL/day commercial noni juice (Tahitian Noni) used in most published trials • Up to 12 oz four times daily was tolerated short-term in the NCI phase I cancer trial • Capsules / dried fruit powders 500–2,000 mg/day — no studied dose
2. Higher studied dose
12 oz four times daily (≈1.4 L/day) in the NCI phase I dose-escalation in advanced cancer patients, short-term. No long-term high-dose safety data.
3. Timing
Take with or without food. Strong, distinctive taste — most users mix with juice or take in divided doses.
4. With food
Either works. Some users find with food reduces the bitter aftertaste.
5. Split dosing
Divided 2–3× daily is common; the NCI phase I used 4× daily for tolerability of larger volumes.
6. How long to try
If trying it, stop at 8–12 weeks if you don't notice the benefit you hoped for. Check LFTs at baseline and at 4–8 weeks given the hepatotoxicity signal, especially if continuing beyond 1–2 months.

What to track

Liver function (ALT, AST, bilirubin) before starting and periodically — especially if continuing >1 month
Any new fatigue, jaundice, nausea, dark urine, right-upper-quadrant pain — stop immediately and get LFTs
Whatever symptom you're targeting (joint pain VAS, fatigue scale) — most users see no measurable change
Potassium if you have kidney disease — noni is relatively high in potassium

Bottom line: If you decide to try it, use a commercial product, take 30–60 mL/day, get baseline LFTs, and stop at any sign of liver symptoms or by 8–12 weeks if you don't see the benefit you wanted.

3 commercial forms

Compare the main delivery options and what they’re best suited for.

Pasteurized commercial noni juice (Tahitian Noni)

Most studied

The format used in the NCI phase I trial and the Wang 2009 smoker RCT. Standardized processing, predictable dose, lowest microbial risk. Strong taste and high cost vs other formats.

Standardized juice; closest to what has been studied clinically.

Noni fruit powder / capsules

Convenient

Dried-fruit powders in capsule form (typically 500 mg). Avoids the unpleasant taste but no clinical trial has matched powdered noni capsule to the volumes used in juice trials. Dosing equivalence to juice is unclear.

Concentration and bioactive profile vary by drying method; no head-to-head pharmacokinetic data vs juice.

Home-fermented noni juice

Avoid

Traditional home preparation involves fermenting whole fruit for weeks. Microbial contamination and inconsistent bioactive content make this the riskiest optionincluding for the hepatotoxicity concern.

Unpredictable composition; not what trials used.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

nausealoose stoolsstrong unpleasant tasteoccasional GI cramping

Serious risks

Who should avoid it

Pregnancy & breastfeeding

Avoid in pregnancy and breastfeeding. No human safety data; noni has a history of traditional use as an emmenagogue (abortifacient) in Polynesia, and the hepatotoxicity signal adds further concern.

Bottom line: The hepatotoxicity case reports are the dominant safety story. Avoid if you have liver disease, get baseline and periodic LFTs if you use it, and stop at any liver symptom.

Interactions

hepatotoxic medications (acetaminophen at high doses, methotrexate, isoniazid, amiodarone, anti-TB drugs, valproate)Major

Noni juice has been associated with case reports of acute hepatitis; combining with other hepatotoxic drugs amplifies risk.

warfarinModerate

Case reports of altered INR (mostly elevations) with noni juice; mechanism unclear (possibly via vitamin K content or hepatic enzyme effects). Monitor INR more closely if you start or stop noni while on warfarin.

potassium-sparing diuretics (spironolactone, amiloride, triamterene)Moderate

Noni juice is relatively high in potassium. Combined with potassium-sparing agents, hyperkalemia risk rises.

ACE inhibitors / ARBsModerate

Both raise serum potassium; noni's potassium load can compound the effect.

Food sources

Noni fruit, fresh (Morinda citrifolia)

Amount
Whole fruit (~100 g)
%DV

Pasteurized noni juice

Amount
30–60 mL
%DV

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for

Single-source commercial juice from established processor (Tahitian Noni / Morinda is the most-studied brand)
Pasteurized — fermented homemade noni juice has higher risk of microbial contamination and inconsistent composition
Clear ingredient list — many products mix noni with grape, blueberry, or other juices that confuse dosing
Stated noni concentration if not pure — 'noni-based blend' may contain very little actual noni
Refrigeration / opacity claims that match the strong taste and dark color you'd expect; if it's bland and pale, it may be heavily diluted

Be skeptical of

Cancer prevention or treatment claims — no human efficacy evidence; phase I NCI trial was safety only
'Detoxifies' / 'cleanses' the liver — particularly ironic given the hepatotoxicity signal
Cures for chronic disease (diabetes, autoimmune, infectious disease) — no controlled trial evidence
Anti-aging / longevity benefits — no human outcome data
Mega-dose multi-bottle 'protocols' marketed by MLM-style sales structures — higher cumulative dose without higher evidence
Combination 'super juice' products — the science such as it exists is for noni alone, not the blend

Frequently asked questions

Is noni juice safe for the liver?

There have been documented case reports of liver toxicity associated with noni juice consumption, including cases severe enough to require transplantation. People with liver disease or on hepatotoxic medications should avoid noni.

Why does noni smell so bad?

Ripe noni fruit produces hexanoic and octanoic acids, giving it a strong cheesy or rancid odor that many people find unpleasant. Aging (fermenting) the juice modifies the smell somewhat. Commercial products often blend in other juices to mask the taste.

Are noni's health claims supported by research?

Many marketed health claims are not well supported by rigorous clinical research. Most studies are small, often industry-sponsored, and have not been independently replicated.

How much noni juice should I drink?

Studies have used a wide range, from 30 mL to several hundred mL daily. There is no established optimal dose. Start small to assess tolerance and risk.

Can I take noni if I have kidney problems?

Noni is very high in potassium. People with kidney disease or on potassium-restricted diets should not consume noni without medical guidance.

References by claim

Cancer (adjunct or treatment)

Memorial Sloan Kettering — About HerbsNoni Monograph (2023) link

Issell et al., 2009PubMed — Journal of Dietary Supplements (2009) link

Safety

LiverTox — NIHNoni Juice Monograph (NIDDK/NIH Bookshelf) (2020) link

EFSA Panel on Dietetic Products, 2009EFSA Journal (Tahitian Noni juice safety opinion) (2009) link

Stadlbauer et al., 2008PubMed — World Journal of Gastroenterology (2008) link

Yu et al., 2011PubMed — Hepatology (2011) link

Stadlbauer et al., 2005PubMed — World Journal of Gastroenterology (2005) link

Joint pain / arthritis

West et al., 2018PubMed — Food Science & Nutrition (2018) link

Oxidative stress in heavy smokers

Wang et al., 2009PubMed — Annals of the New York Academy of Sciences (2009) link

Track Noni with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 31, 2026·Evidence current as of May 31, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.